Which document demonstrates compliance with labeling regulations and the appropriateness of instructions provided to subjects?

Which document demonstrates compliance with labeling regulations and the appropriateness of instructions provided to subjects?

• A. Sample of Labels Attached to Investigational Product Containers
• B. IRB/IEC Composition
• C. Regulatory Authorities Authorization/Approval/Notification of Protocol
• D. Dated, Documented Approval/Favorable Opinion of IRB/IEC

Answer: (A)

The main concept tested is ensuring that how the investigational product is presented to subjects is compliant with labeling rules and that the instructions on how to use the product are appropriate. The best document to demonstrate this is the sample of labels attached to investigational product containers. This artifact shows exactly what information is on the label—product name, strength, lot/serial number, storage conditions, expiration date, and any dosing or usage instructions or warnings—and whether that content aligns with the protocol and regulatory requirements. It provides concrete evidence that labeling standards are being met and that instructions intended for subjects are clear and properly conveyed on the product itself. The other documents focus on oversight or approval rather than the actual labeling content. IRB/IEC composition reveals who reviews the study, not what is on the product label. Regulatory authorities’ authorization/approval pertains to protocol clearance, not labeling specifics. A dated, documented approval or favorable opinion confirms ethical review but doesn’t show the labeling details or subject-use instructions.

The main concept tested is ensuring that how the investigational product is presented to subjects is compliant with labeling rules and that the instructions on how to use the product are appropriate. The best document to demonstrate this is the sample of labels attached to investigational product containers. This artifact shows exactly what information is on the label—product name, strength, lot/serial number, storage conditions, expiration date, and any dosing or usage instructions or warnings—and whether that content aligns with the protocol and regulatory requirements. It provides concrete evidence that labeling standards are being met and that instructions intended for subjects are clear and properly conveyed on the product itself.

The other documents focus on oversight or approval rather than the actual labeling content. IRB/IEC composition reveals who reviews the study, not what is on the product label. Regulatory authorities’ authorization/approval pertains to protocol clearance, not labeling specifics. A dated, documented approval or favorable opinion confirms ethical review but doesn’t show the labeling details or subject-use instructions.